A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure

por Wang, Zhenya, Shi, Wei, Wu, Taibo, Peng, Tian, Wang, Xiaoming, Liu, Shuaiyang, Yang, Zifeng, Wang, Jia, Li, Peng-Long, Tian, Ruifeng, Hong, Ying, Yang, Hailong, Bai, Lan, Hu, Yufeng, Cheng, Xu, Li, Hongliang, Zhang, Xiao-Jing, She, Zhi-Gang
Publicado 2023